Blood Products

Products for In-Vitro Use:

Stanford Blood Center provides blood products for in-vitro investigational use. Tubes or whole units of blood may be collected from individuals selected by the researcher or recruited by the Blood Center. Products collected for in-vitro investigational use are not routinely tested for infectious disease markers, although donor pre-screening can be arranged. Because products for in-vitro use do not meet the same safety criteria as blood products for transfusion, these components must not be used for infusion or for manufacturing into infusible products.

Products for In-Vivo Use (Clinical Trials):

Stanford Blood Center collects blood products for investigational in-vivo use. Products may be collected from patients for re-infusion into the same patient (autologous donors), from relatives of patients (directed donors) or from normal healthy donors (allogeneic donors). IRB approval is required for all trials involving investigational in-vivo use of blood products.

CONTACT US

Monday – Friday, 8:00 am – 5:00 pm
Phone: 650-724-2997
Email: sbc-clients@stanford.edu

Clinical Trials

Monday – Friday, 8:30 am – 4:30 pm
Phone: 650-724-2997
Email: sbc-clients@stanford.edu

Routine Product Standing Orders (Current Customers)

Pickups: Monday – Friday, 8:30 am – 8:30 pm
Questions: 650-724-2997

Billing Information

Monday – Friday, 8:00 am – 4:30 pm
Phone: 650-723-7994
Email: BloodCenter-AR@stanford.edu

Product Specifications Legend

HCT Hematocrit
Lymph Lymphocytes
Mono Monocytes, eosinophils, basophils, and other large mononuclear cells such as blasts, metamyelocytes, myelocytes, etc.
Gran Granulocytes, including Neutrophils, Eosinophils and Basophils

The following products are available for in-vivo or in-vitro use (except as noted):

Leukocytes (White Blood Cells)

Tubes Only

Anticoagulants and Additive Solutions

ACD-A Anticoagulant Citrate Dextrose solution USP (ACD) Formula A

  • Dextrose (monohydrate)
  • Sodium Citrate (dihydrate)
  • Citric Acid (anhydrous)

AS-3 Additive Solution Formula 3 (100mL added to ACD-A Red Blood Cells collected by apheresis)

Each 100 mL contains:

  • Dextrose (monohydrate), USP 1.10 g
  • Sodium Citrate (dihydrate), USP 0.588 g
  • Sodium Chloride, USP 0.410 g
  • Monobasic Sodium Phosphate (monohydrate), USP 0.276 g
  • Citric Acid (monohydrate), USP 0.042 g
  • Adenine 0.030 g

CPD Anticoagulant Citrate Phosphate Dextrose USP

  • Sodium Citrate (dihydrate) 26.3 g/L
  • Dextrose (monohydrate) 25.5 g/L
  • Citric Acid (anhydrous) 3.27 g/L
  • Monobasic Sodium Phosphate (monohydrate) 2.22 g/L

AS-1 Adsol® additive formula (added to CPD Red Blood Cells)

  • Sodium Citrate (dihydrate) 26.3 g/L
  • Dextrose (monohydrate) 25.5 g/L
  • Citric Acid (anhydrous) 3.27 g/L
  • Monobasic Sodium Phosphate (monohydrate) 2.22 g/L
  • Sodium Chloride
  • Mannitol
  • Adenine

CP2D Anticoagulant Citrate Phosphate Dextrose Adenine Solution USP

  • Dextrose (monohydrate) 31.9 g/L
  • Sodium Citrate (dihydrate) 26.3 g/L
  • Citric Acid (anhydrous) 3.27 g/L
  • Monobasic Sodium Phosphate (monohydrate) 2.22 g/L
  • Adenine 0.275 g/L

(In order of Research Products and Services tables)